Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

US Patent 11970534 · Granted Apr 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Loading nucleic acids onto substrates2025
Methods of treating cancer using antibodies and molecules that immunospecificall2025
Methods of treating cancer using antibodies and molecules that immunospecificall2025
Methods for selecting antibodies that specifically bind glycosylated immune chec2024
Antibodies specific to glycosylated PD-1 and methods of use thereof2024
Antibodies specific to glycosylated PD-L1 and methods of use thereof2024
Methods of cancer treatment and therapy using a combination of antibodies that b2023
Dual function antibodies specific to glycosylated PD-L1 and methods of use there2023
Loading nucleic acids onto substrates2023
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfata2023
Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or2023
Antibodies specific to glycosylated BTLA (B- and T- lymphocyte attenuator)2022